Phoenix Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Phoenix Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$441K	Hold	2,784	–	–	﹤0.01%	360
2026 Q1	$356K	Sell	2,784 -2,538	-48%	-$317K	﹤0.01%	355
2025 Q4	$649K	Sell	5,322 -10,200	-66%	-$1.17M	0.01%	268
2025 Q3	$1.56M	Buy	15,522 +2,714	+21%	+$244K	0.02%	203
2025 Q2	$1.06M	Sell	12,808 -265,255	-95%	-$21.2M	0.01%	232
2025 Q1	$22.6M	Sell	278,063 -304,026	-52%	-$27.2M	0.35%	53
2024 Q4	$52.4M	Sell	582,089 -112,600	-16%	-$10.9M	0.72%	33
2024 Q3	$68.6M	Sell	694,689 -52,468	-7%	-$5.16M	1.01%	29
2024 Q2	$69.3M	Sell	747,157 -356,947	-32%	-$32M	1.05%	29
2024 Q1	$105M	Sell	1,104,104 -206,286	-16%	-$19.1M	1.45%	17
2023 Q4	$132M	Sell	1,310,390 -840,969	-39%	-$62.5M	2.18%	11
2023 Q3	$157M	Buy	2,151,359 +17,221	+0.8%	+$1.38M	2.88%	8
2023 Q2	$178M	Hold	2,134,138	–	–	3.63%	7
2023 Q1	$163M	Buy	2,134,138 +642,073	+43%	+$53.3M	3.63%	5
2022 Q4	$124M	Buy	1,492,065 +597,000	+67%	+$48.3M	2.4%	11
2022 Q3	$70.6M	Sell	895,065 -23,782	-3%	-$2M	1.56%	19
2022 Q2	$68.2M	Buy	918,847 +119,342	+15%	+$8.96M	1.4%	20
2022 Q1	$71.9M	Hold	799,505	–	–	1.21%	24
2021 Q4	$89.5M	Buy	799,505 +231,855	+41%	+$28M	1.48%	17
2021 Q3	$71.4M	Buy	+567,650	New	+$73.1M	1.24%	20
2021 Q2	–	Sell	-24,997	Closed	-$3.39M	–	426
2021 Q1	$3.39M	Buy	+24,997	New	+$3.74M	0.08%	171

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Phoenix Financial's XBI Position: Q2 2026 in Review

Phoenix Financial held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,784 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

Phoenix Financial first reported a position in XBI in Q1 2021 and has held it in 21 quarters since. The position peaked at $178M in Q2 2023. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Phoenix Financial held 2,784 shares of State Street SPDR S&P Biotech ETF worth $441K as of Q2 2026.
Phoenix Financial left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Phoenix Financial's portfolio in Q2 2026, its #360 holding.
Phoenix Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 21 quarters since.
Phoenix Financial's State Street SPDR S&P Biotech ETF position peaked at $178M in Q2 2023.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.